- Low bankruptcy risk (Altman Z-Score: 11.06)
- Highly efficient cash conversion (100% FCF/OCF ratio)
- Trading above its 200-day moving average
Stronger technical forecast for Vaxcyte, Inc. stock price after Thursday trading
(Updated on Jun 18, 2026)
The Vaxcyte, Inc. stock price gained 1.52% on the last trading day (Thursday, 18th Jun 2026), rising from $50.67 to $51.44. During the last trading day the stock fluctuated 6.45% from a day low at $50.24 to a day high of $53.48. The price has risen in 6 of the last 10 days and is up by 5.5% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $116.04 million.
The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $53.16 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -19.84% during the next 3 months and, with a 90% probability hold a price between $35.41 and $42.61 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
PCVX Signals & Forecast
Mostly positive signals in the chart today. The Vaxcyte, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $48.74 and $50.70. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 13.25%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
Support, Risk & Stop-loss for Vaxcyte, Inc. stock
Vaxcyte, Inc. finds support from accumulated volume at $49.56 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.24 between high and low, or 6.45%. For the last week, the stock has had daily average volatility of 4.73%.
Our recommended stop-loss: $49.38 (-4.00%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 6 days ago.)
Trading Expectations (PCVX) For The Upcoming Trading Day Of Monday 22nd
For the upcoming trading day on Monday, 22nd we expect Vaxcyte, Inc. to open at $51.72, and during the day (based on 14 day Average True Range), to move between $50.32 and $52.56, which gives a possible trading interval of +/-$2.24 (+/-4.46%) up or down from last closing price. If Vaxcyte, Inc. takes out the full calculated possible swing range there will be an estimated 4.46% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $51.48 (0.08%) than the support at $49.56 (3.65%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Vaxcyte, Inc. stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.
Current score:
4.079
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 22, 2026 - $51.72 ( 0.544%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
PCVX Performance
Trading levels for PCVX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 54.96 | 6.84% |
| R2 | 53.72 | 4.44% |
| R1 | 52.96 | 2.95% |
| Price | 51.44 | |
| S1 | 50.48 | -1.86% |
| S2 | 49.72 | -3.35% |
| S3 | 48.48 | -5.75% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 58.50 | 13.72% |
| R2 | 54.72 | 6.38% |
| R1 | 51.48 | 0.0778% |
| Price | 51.44 | |
| S1 | 49.56 | -3.65% |
| S2 | 47.29 | -8.07% |
| S3 | 47.17 | -8.30% |
FAQ
Click here for our free guide on how to buy Vaxcyte, Inc. Stock.
Buy PCVX